
    
      In the phase of recruitment, of 20 months of duration, there will be included 16 participants
      who will be randomized to one of the groups of intervention (8 patients group CMMAd / 8
      patients group placebo). The phase of follow-up of every patient will be 12 months, though,
      provided that these patients are seen regularly in the study sites of the study, once
      concluded his follow-up will be continued to be able to obtain safety information and
      efficacy to 24 months.
    
  